Boyuan capital announced that it had completed the raising of RMB phase II fund and was oversubscribed
Boyuan capital announced that it had completed the raising of RMB phase II fund and was oversubscribed, with a total subscription scale of more than 3 billion yuan. It is reported that since its surrender, Boyuan RMB phase II fund has invested in more than a dozen enterprises, such as Boya serine, Diluo, feitland, qicarbon technology, tengfu medical treatment and Zhixiang biology. Boyuan capital is an investment institution focusing on investing and incubating Chinese medical and health start-ups.
This text is a result of machine translation.
Related companies：
In-depth
Consumer Staples, Technology
Smart IoT Device Brings Future Homes into Focus, but Sparks with Interoperability Issue
With the dawn of home automation having been heralded for years, the 'smart' label of in-home products as forthcoming additions has become ubiquitous in the sustainable technology market. Global companies sought to further underline their credentials in home automation which led to a massive stretch of the imagination from smart light bulbs and thermostats to doorbells.
Jun 02, 2022 10:07 PM
Briefing Jun 28, 2022 01:54 PM
· Financials
Suspension of large amount subscription of Jingshun great wall reform opportunity hybrid fund
Jan 30, 2024 07:59 PM
Dec 11, 2023 08:49 PM
Jan 05, 2023 07:33 PM
Dec 28, 2021 06:19 PM
Briefing Jun 27, 2022 12:35 PM
· Automotive
According to the German business daily, Mercedes Benz will stop manufacturing class a cars around 2025.
Briefing Jun 27, 2022 12:14 PM
· Communication
Tencent QQ responded to large-scale account theft: the affected area has been controlled and criminal evidence of Mafia gangs is being collected
Briefing Jun 21, 2022 10:59 AM
· Consumer Staples
Meta universe concept stocks move up
See more
Read next
Insight
In-depth
Insight
In-depth